Publication | Closed Access

Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis

Tumor BiologyOncologyCyld/ripk1/fadd/caspase-8-dependent ApoptosisMedicineApoptosisSynergistic ActivationCell DeathImmune Checkpoint InhibitorAnti-cancer AgentCancer CellsCancer TreatmentRadiation OncologyCancer BiologyCell BiologyCancer Research